Simulations Plus Closes Cognigen Buy

Lancaster-based Simulations Plus, which provides simulation and modeling software for the pharmaceuticals industry, said Tuesday that it has completed its acquisition of Cognigen Corporation. The deal was worth $7.0M, including $2.8M in cash and $4.2M in stock. Simulations Plus said the deal adds 30 new employees to the company, and also is expected to add approximately $5.0M in revenues in the coming fiscal year. Cognigen was based in New York. The deal had been announced on July 23rd.